Connect with us


Gawk Inc. (OTCMKTS: GAWK) Positions Itself Within Two Growing Industries



Both the cloud computing and telecommunications industries are projected to grow at steady rates in the coming years. A recent study has projected that cloud-computing infrastructure and platforms spending will increase at an annually compounded growth rate of nearly 30% from 2013 to 2018. Public cloud Infrastructure as a Service spending in 2015 was reported at $33 billion, while in 2016 it is projected to reach $50 billion, and grow to $104 billion as soon as 2018. This growth is accentuated by the fact that IT managers were polled and reported that cloud-computing is within their top three organizational focuses for the coming year.

Meanwhile, the telecommunication industry is positioned to grow at a steady rate as well. In 2015, the telecommunications industry grew at a rate of 2.2% with projected growth through 2019 remaining stable at a rate of over 2.0%. In 2014, North American spending on telecommunications was reported at $399 billion with 2017 spending projected to reach levels as high as $424 billion. In addition, Asian and Pacific spending on telecommunication services is expected to reach $568 billion after closing at reported levels of $519 billion in 2014.

The micro-cap company, Gawk, Inc. (OTCMKTS:GAWK), has been increasing its market share in both the telecommunication and cloud-computing industries through various acquisitions. Gawk, Inc. is in the business of meeting its client’s telecommunication and cloud-computing needs through services that are global, can be utilized by companies of various sizes, and are cutting edge from a technical standpoint. Headquartered in Los Angeles, Gawk, Inc. has recently acquired three companies: Connexum LLC., WebRunners, Inc., and NetD Consulting, Inc. in an effort to orchestrate their mission to provide services of the utmost quality.

On February 23rd, the company released a statement to its shareholders highlighting its increasing revenue streams. The release displays how at the beginning of the past fiscal year, Gawk, Inc. (OTCMKTS:GAWK)’s revenues were nearing $19,000 a month, yet following its recent acquisition of Connexum LLC., their revenues were growing closer to $19,000 a day. This increase has launched Gawk, Inc. into becoming a positive net cash flow company, and no longer is dependent on outside capital to further its growth strategy. On December 17th, 2015, Gawk, Inc. released its quarterly report, which highlighted how its yearly revenue was up 1089% from the same time in the previous year. Meanwhile, the quarterly report also displayed how their annual operating expenses were reduced by 374% and their liabilities were reduced by $1,239,571 in the final quarter of 2015.

In a previous press release, Gawk, Inc. officially announced it’s acquisition of Connexum LLC, which bolstered the companies standing within the telecommunications industry. When speaking on the acquisition’s effect on his company, Gawk, Inc.’s CEO Scott Kettle said, “We now are also a Full Service business class telecom provider, providing Hosted PBX services, competing directly with 8X8, Vonage, and other market leaders… Our new software development team will accelerate our time to market with new, innovative features and customized solutions that our customers need, now and into the future.” Kettle continued with his statement, now pertaining to his vision regarding further acquisitions in the future, “We are moving forward with negotiations for several data centers we have identified in the Midwest and on the East Coast. We have announced recently a series of important customer wins, and our business plan calls for a national chain of GAWK data centers, and expanding internationally from there.”

The Connexum LLC acquisition press release was published on February 2nd, and the market reacted favorably to the announcement. Looking back to January 12th, GAWK closed at $0.0074, and then moving to the day of the press release, GAWK closed at $0.0089. Over this time period, Gawk, Inc.’s stock GAWK saw a total return of 20.27%. Looking more closely, GAWK grew at an average daily rate of 1.61% highlighting the equity’s ability to grow steadily. However, the company also displayed its ability to produce returns to its shareholder’s in short amounts of time. For example, on February 1st GAWK produced a daily return of 12.50% and then grew again the next day at a rate of 9.88%.

In summation, Gawk, Inc. offers its customers a premier suite of services to meet both their telecommunications and cloud-computing needs. Those two industries have shown steady recent historical growth, with projections in line with continuing this trend. Gawk, Inc. has grown, through acquisitions of profitable companies, to a point of sustained internal growth, and the market has since reflected this information.


CytoDyn Inc (OTCMKTS:CYDY) Regains Momentum After The Big Announcement




Now that the market seems to be coming back into his elements, it could be time for investors to start looking into penny stocks more closely. These stocks may often be risky, but if one makes the right choice, then the rewards could be enormous. One penny stock that could be put into the watch list at this point in time is that of CytoDyn Inc (OTCMKTS:CYDY).

The late-stage biotechnology company, which is developing the coronavirus medicine leronlimab, announced last week that it had filed a comprehensive application for uplisting on NASDAQ. The company announced that it believes that its application satisfies the myriad listing requirements of the NASDAQ Capital Market.

The Chief Executive Officer and President of the company Nader Pourhassan stated that while it is true that the entire process is expected to take many weeks, CytoDyn is hopeful of success in this matter.

He went on to state that a listing on NASDAQ will not only provide shareholders with more liquidity but also give CytoDyn much bigger access to fresh capital. It is a significant development for the company, and the market participants realized it as well. After the announcement was made, the stock rallied by as much as 50%. Investors could do well to keep an eye on the stock this week.

While the rally following this announcement was a welcome relief for the company, it is important to point out that earlier on in the week, the stock has fallen considerably following a setback. Last Monday, the company announced that the United States Food and Drug Administration handed CytoDyn a refusal to file a letter with regards to the usage of leronlimab to treat HIV.

However, at the same time, investors should be noted that the company did announce that it is confident of furnishing the agency with all the further details that have been demanded. It is one of the penny stocks that have performed remarkably well this year so far, and investors could keep an eye on it.

Continue Reading


These 3 Pot Stocks Are Up Big Since May: What’s the Buzz?




Over the course of the past year or so, pot stocks had generally struggled, but during the past month, those stocks have recovered nicely. The stock market suffered a historic fall due to the economic turmoil caused by the coronavirus pandemic. It is believed that investors who are looking for value have descended on the beaten-down pot stocks. On the flip side, these stocks could also have been identified as defensive plays in an uncertain market environment.

That being said, it should be noted that despite the gains recorded by many stocks, most of those stocks are still considerably lower than the all-time highs. In such a situation, it could be worthwhile for investors to take a closer look at some of the strongest and more stable cannabis companies in the industry. Here is a look at three pot stocks that made significant moves in May and could be tracked by investors at this point.

1. HEXO Stock Jumps Ahead of Earnings

HEXO Corp (TSX:HEXO) (NYSE:HEXO) is one of those cannabis companies which have had a particularly tough time over the past year or so. However, the stock has emerged as one of the bigger gainers among pot stocks in recent trading sessions. The Hexo stock has gained as much as 120% over the course of the past month. The company is all set to release its financial results for the fiscal third quarter on Thursday, and hence, it could be a big week for the stock.

The recent surge in the Hexo stock may have come as a major boost to investors, but it should be noted that over the past year, it recorded considerable losses. The beaten-down nature of the stock may have contributed to the stock becoming more attractive for investors. However, the trajectory of the Hexo stock in the near term is going to depend a lot on its third-quarter earnings.

The company had made a loss of $298 million in the previous quarter, and while it is almost certain that it is going to make a loss again, the size of the loss is going to be keenly watched. Additionally, any writedowns are also going to be harmful to the stock. Investors should also keep an eye on sales growth.

2 Organigram gains Momentum on Value Buying

Organigram Holdings (TSX:OGI) (NASDAQ:OGI) is another pot stock that has made significant gains in the past month. Since May 13, the stock has gained as much as 80%. In April, the company announced its fiscal second-quarter results, but it had been a disappointment.

Revenues dropped by 13.7% year on year to hit CA$23.2 million, and losses widened to CA$6.8 million from CA$6.4 million in the prior-year period. However, one significant cause for optimism for Organigram investors is the fact that in the second quarter, cannabis 2.0 products made up as much as 13% of its revenue. That has opened up a whole new opportunity for the company.

Wholesale cannabis revenue made up 24% of the net, and that is again a new source of revenue. The company blamed the lower volumes of flower as well as cannabis oil for the drop in sales. Organigram reported cash and cash equivalents of CA$41.1 million as of February 29. Considering the fact that it has burned CA$25 million in the past six months, investors should not use that the cash balance does not paint a pretty picture.

3 Aphria Recovers Following Solid Earnings

Aphria (TSX:APHA) (NYSE:APHA), on the other hand, managed to perform relatively well in its fiscal third quarter. The net sales rose by as much as 19.7% sequentially to hit CA$144.4 million, and more importantly, the company also managed to record a profit for the third time in four quarters. On top of that, it should be noted that although the Canadian cannabis company spends CA$124.4 million on its operations in the nine months trailing that quarter, it still reported a cash balance of CA$515 million.

The performance seems to have buoyed market participants as well, and the stock has rallied by as much as 75% since the middle of May. One of the most important things that investors are going to be looking into is whether Aphria is going to be able to maintain its profitability.

However, due to the turmoil caused by the coronavirus pandemic, it might prove difficult. That being said, it should be noted that the pandemic is going to have an equally damaging effect across the sector.

Continue Reading


ConforMIS Inc (NASDAQ: CFMS): Premium Members Made A Quick 65% Profit In Just 1 week



Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here
JOIN US NOW: For Details Contact us at

Or You can send me a friend request on facebook here

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy ConforMIS Inc (NASDAQ: CFMS) yesterday (march 13th) at $1.36. Now look at the price of the stock – its up 65% at $2.25 from our buy price. This is how easy money they made. If you had invested $5,000 in CFMS, it could had been moved up to $8,250. It’s not yet late, join us at

Continue Reading